Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Super League Gaming's Return On Capital Employed Overview

Benzinga Pro data, Super League Gaming (NASDAQ:SLGG) reported Q1 sales of $3.77 million. Earnings fell to a loss of $7.92 million, resulting in a 10.98% decrease from last quarter.

Benzinga

Looking Into Surgepays's Return On Capital Employed

According to Benzinga Pro data, during Q1, Surgepays (NASDAQ:SURG) posted sales of $21.14 million. Earnings were up 81.81%, but Surgepays still reported an overall loss of $1.24 million.

Benzinga

Impel NeuroPharma's Return On Capital Employed Insights

Impel NeuroPharma (NASDAQ:IMPL) brought in sales totaling $1.76 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 9.0%, resulting in a loss of $26.97 million.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Orbital Energy Group Earnings Perspective: Return On Invested Capital

Orbital Energy Group (NASDAQ:OEG) brought in sales totaling $70.25 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 51.08%, resulting in a loss of $37.62 million.

Benzinga

Luna Innovations's Return on Invested Capital Overview

According to Benzinga Pro, during Q1, Luna Innovations (NASDAQ:LUNA) earned $9.58 million, a 508.32% increase from the preceding quarter. Luna Innovations's sales decreased to $22.48 million, a 7.19% change since Q4.

Benzinga

Syros Pharmaceuticals Earnings Perspective: Return On Capital Employed

Syros Pharmaceuticals (NASDAQ:SYRS) brought in sales totaling $5.47 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 5.6%, resulting in a loss of $25.15 million.

Benzinga

Analyst Ratings for Netflix

Analysts have provided the following ratings for Netflix (NASDAQ:NFLX) within the last quarter:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Analyst Ratings for Micron Technology

Within the last quarter, Micron Technology (NASDAQ:MU) has observed the following analyst ratings:

Benzinga

4 Analysts Have This to Say About CrossFirst Bankshares

CrossFirst Bankshares (NASDAQ:CFB) has observed the following analyst ratings within the last quarter:

Benzinga

Jim Cramer Says This Is A Terrific Stock

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rapid7, Inc. (NASDAQ: RPD) doesn’t make money, so he will not go for it.

Benzinga

Fastenal And 2 Other Stocks Insiders Are Buying

Although the Nasdaq Composite gained more than 150 points on Friday, there were a few notable insider trades.

Benzinga

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Here's Why Elon Musk Wants You To Watch 'Idiocracy'

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk went on Twitter to share his thoughts about many of his friends not having kids.

Benzinga

Leaked Report Says Amazon May Run Out Of People To Hire In US by 2024

According to a new report, a leaked Amazon.com, Inc (NASDAQ: AMZN) internal memo from mid-2021 suggests that the company may face a resource crunch and may run out of people to hire at the company's U.S.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Here's How Much Someone Just Paid To Have Lunch With Warren Buffett

Someone submitted a winning bid of $19,000,100 to have lunch with Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B) CEO Warren Buffett during the final eBay Inc (NASDAQ:

Benzinga

Benzinga Bulls And Bears Of The Week: Tesla, Netflix, General Motors, Disney And A Company Betting Big On Bitcoin

Benzinga has examined the prospects for many investors' favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro.

Benzinga

MNOV: Positive Results for MN-166 (Ibudilast) in Patients at Risk of Acute Respiratory Distress Syndrome…

By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT

Benzinga

CLSN: OVATION 2 Study 85% Enrolled…

By David Bautz, PhD NASDAQ:CLSN READ THE FULL CLSN RESEARCH REPORT

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

EXCLUSIVE: Benzinga's 2022 Esports Listmakers Are Driving Gaming Forward

Financial media and data company Benzinga is capitalizing on its mission to bridge the gap between retail and institutional investors by holding free virtual events featuring speakers from innovative companies.

Benzinga

Regeneron Pharmaceuticals Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Regeneron Pharmaceuticals. Looking at options history for Regeneron Pharmaceuticals (NASDAQ:REGN) we detected 34 strange trades.

Benzinga

This Is What Whales Are Betting On Lucid Gr

A whale with a lot of money to spend has taken a noticeably bullish stance on Lucid Gr. Looking at options history for Lucid Gr (NASDAQ:LCID) we detected 27 strange trades.

Benzinga

Check Out What Whales Are Doing With MELI

A whale with a lot of money to spend has taken a noticeably bearish stance on MercadoLibre. Looking at options history for MercadoLibre (NASDAQ:MELI) we detected 36 strange trades.

Benzinga

Pinduoduo Whale Trades For June 17

Someone with a lot of money to spend has taken a bullish stance on Pinduoduo (NASDAQ:PDD). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Gores Guggenheim Soars As Polestar Merger Approaches: Here's How The EV SPAC Looks

Gores Guggenheim Inc (NASDAQ: GGPI) was soaring up more than 13% on Friday, heavily outpacing the general market, which saw the S&P 500 trading up about 0.7%.

Benzinga

Cannabis Movers & Shakers: 22nd Century Group, Houseplant, Proven Media

22nd Century Group Names New CFO 22nd Century Group (NASDAQ: XXII) has appointed f R. Hugh Kinsman to oversee its financial department. Kinsman is currently CFO of GVB Biopharma, which 22nd Century acquired effective May 13, 2022.

1 … 437 438 439 440

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Berkshire Hathaway Inc

116 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.